The New York-based company, founded in 2012, manages a long-short equity fund and invests in early-stage to late-stage private investments. With over $2.2 billion in assets under management, Casdin Capital works closely with industry leaders to fuel their visions and identify key innovations in the biotechnology, healthcare, life science, information technology, and industrial sectors. The firm's core principles include deep analysis, intellectual honesty, hard work, and partnerships with the best people.